Prestige Consumer Healthcare
277 hedge funds and large institutions have $2.97B invested in Prestige Consumer Healthcare in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 86 increasing their positions, 128 reducing their positions, and 28 closing their positions.
416% more call options, than puts
Call options by funds: $397K | Put options by funds: $77K
1.45% less ownership
Funds ownership: 101.83% → 100.38% (-1.4%)
2% less funds holding
Funds holding: 282 → 277 (-5)
6% less capital invested
Capital invested by funds: $3.16B → $2.97B (-$190M)
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
33% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 128
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$18.9M |
| 2 |
Man Group
London,
United Kingdom
|
+$5.8M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$4.67M |
| 4 |
Millennium Management
New York
|
+$4.01M |
| 5 |
AI
Ariel Investments
Chicago,
Illinois
|
+$3.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$20.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.1M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$7.84M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$7.24M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$7.08M |
PBH Hedge Fund Activity: Q2 2023 in Review
277 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2023, worth a combined $2.97B — down 6% from $3.16B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of PBH and 24 opened new positions — a net loss of 4 holders — while 128 trimmed existing stakes and 86 added.
The largest buyer was Macquarie Group, adding an estimated $18.9M. The largest seller was Envestnet Asset Management, cutting an estimated $20.6M.
- 277 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2023, down from 282 in Q1 2023.
- Funds reported $2.97B of Prestige Consumer Healthcare stock for Q2 2023, down 6% quarter-over-quarter.
- 24 funds opened new Prestige Consumer Healthcare positions in Q2 2023 and 28 closed out, a net change of -4 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2023 was Macquarie Group, an estimated $18.9M added.
- The largest Prestige Consumer Healthcare seller in Q2 2023 was Envestnet Asset Management, an estimated $20.6M sold.
Based on aggregated 13F filings for Q2 2023.